FDA

Pharma’s concerns pile up months after Supreme Court’s landmark Chevron decision
Pharma Voice
Wed, 08/21/24 - 11:18 am
Supreme Court
Chevron Doctrine
FDA
CMS
Inflation Reduction Act
Lawmakers urge FDA to investigate clinical trials run in tandem with China's military
Fierce Pharma
Tue, 08/20/24 - 10:06 pm
FDA
China
clinical trials
Biosecure Act
FDA declines to approve Regeneron's blood cancer therapy
Reuters
Tue, 08/20/24 - 09:59 pm
Regeneron
FDA
linvoseltamab
Multiple Myeloma
Targeting AZ's Tagrisso, Johnson & Johnson's Rybrevant combo wins key FDA nod in first-line lung cancer
Fierce Pharma
Tue, 08/20/24 - 11:36 am
JNJ
AstraZeneca
FDA
non-small cell lung cancer
Rybrevant
Lazcluze
Tagrisso
BMS’ KarXT nears schizophrenia approval, but AbbVie and others wait in the wings
Pharma Voice
Mon, 08/19/24 - 09:58 am
Bristol Myers Squibb
KarXT
FDA
schizophrenia
AbbVie
Liquida Misses Full Approval for Pulmonary Hypertension Drug as Competitor Retains Market Exclusivity
BioSpace
Mon, 08/19/24 - 09:57 am
Liquida
Yutrepia
pulmonary hypertension
FDA
Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived
Motley Fool
Sun, 08/18/24 - 09:19 pm
Eli Lilly
FDA
obesity
Zepbound
Lykos co-founder Doblin to step down after MDMA setback
Pharmaphorum
Fri, 08/16/24 - 11:14 am
Lykos Therapeutics
Rick Doblin
MDMA
FDA
FDA approves AstraZeneca's non-small cell lung cancer treatment
Reuters
Thu, 08/15/24 - 10:06 pm
AstraZeneca
Imfinzi
FDA
non-small cell lung cancer
The FDA calls them ‘recalls,’ yet the targeted medical devices often remain in use
Medical Marketing and Media
Thu, 08/15/24 - 11:47 am
device recalls
Medtech
FDA
FDA clears use of Cresilon's gel to stop severe bleeding in seconds
Reuters
Thu, 08/15/24 - 11:42 am
Cresilon
FDA
bleeding control
Traumagel
FDA approves Incyte's treatment for chronic graft-versus-host disease
Reuters
Wed, 08/14/24 - 10:37 pm
Incyte
FDA
graft vs host disease
Niktimvo
Galderma gets FDA nod for prurigo nodularis therapy
Pharmaphorum
Tue, 08/13/24 - 11:26 am
Galderma
FDA
Nemluvio
prurigo nodularis
Novo Nordisk plots 2024 FDA filing for once-weekly insulin and semaglutide combo
Fierce Pharma
Mon, 08/12/24 - 06:01 pm
Novo Nordisk
FDA
insulin
semaglutide
Icosema
Novartis' Complement Inhibitor Fabhalta Approved for IgAN
Contract Pharma
Mon, 08/12/24 - 05:52 pm
FDA
Novartis
Fabhalta
primary IgA nephropathy
Ascendis scores hard-fought FDA nod for hormone replacement therapy Yorvipath
Fierce Pharma
Mon, 08/12/24 - 11:35 am
Ascendis Pharma
hypoparathyroidism
FDA
Yorvipath
FDA grants IND clearance for TG Therapeutics’ trial of multiple sclerosis treatment
Clinical Trials Arena
Mon, 08/12/24 - 11:25 am
Precision Biosciences
TG Therapeutics
FDA
azer-cel
progressive MS
MS
clinical trials
Article retractions muddy MDMA waters after FDA denial
Pharmaphorum
Mon, 08/12/24 - 11:23 am
MDMA
Lykos Therapeutics
PTSD
FDA
psychedelics
Lykos will ask FDA to reconsider its decision following rejection of MDMA therapy for post-traumatic stress disorder
Fierce Biotech
Sun, 08/11/24 - 01:09 pm
Lykos Therapeutics
FDA
MDMA
PTSD
midomafetamine
FDA approves nasal spray alternative to EpiPen for allergic reactions
Reuters
Sun, 08/11/24 - 01:07 pm
FDA
ARS Pharmaceuticals
allergic reactions
anaphylaxis
EpiPen
Neffy

Pages